The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and HempAmericana are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak
Strong
Over the last 90 days HempAmericana has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, HempAmericana is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
HempAmericana
HempAmericana Relative Risk vs. Return Landscape
If you would invest 0.01 in HempAmericana on November 15, 2025 and sell it today you would earn a total of 0.00 from holding HempAmericana or generate 0.0% return on investment over 90 days. HempAmericana is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than HempAmericana, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
Expected Return
Risk
HempAmericana Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of HempAmericana for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for HempAmericana can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
HempAmericana generated a negative expected return over the last 90 days
HempAmericana has some characteristics of a very speculative penny stock
HempAmericana has a very high chance of going through financial distress in the upcoming years
HempAmericana currently holds 201.68 K in liabilities. HempAmericana has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist HempAmericana until it has trouble settling it off, either with new capital or with free cash flow. So, HempAmericana's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HempAmericana sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HempAmericana to invest in growth at high rates of return. When we think about HempAmericana's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 4.92 K. Net Loss for the year was (894.05 K) with loss before overhead, payroll, taxes, and interest of (9.65 K).
HempAmericana currently holds about 201.6 K in cash with (466.57 K) of positive cash flow from operations.
HempAmericana Fundamentals Growth
HempAmericana Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of HempAmericana, and HempAmericana fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HempAmericana Pink Sheet performance.
Assessing HempAmericana's fundamental ratios provides investors with valuable insights into HempAmericana's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the HempAmericana is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
HempAmericana, Inc. researches, develops, and sells products made of industrial hemp in the United States. HempAmericana, Inc. was founded in 2014 and is based in New York, New York. Hemp Americana operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.
Things to note about HempAmericana performance evaluation
Checking the ongoing alerts about HempAmericana for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for HempAmericana help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
HempAmericana generated a negative expected return over the last 90 days
HempAmericana has some characteristics of a very speculative penny stock
HempAmericana has a very high chance of going through financial distress in the upcoming years
HempAmericana currently holds 201.68 K in liabilities. HempAmericana has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist HempAmericana until it has trouble settling it off, either with new capital or with free cash flow. So, HempAmericana's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HempAmericana sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HempAmericana to invest in growth at high rates of return. When we think about HempAmericana's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 4.92 K. Net Loss for the year was (894.05 K) with loss before overhead, payroll, taxes, and interest of (9.65 K).
HempAmericana currently holds about 201.6 K in cash with (466.57 K) of positive cash flow from operations.
Evaluating HempAmericana's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate HempAmericana's pink sheet performance include:
Analyzing HempAmericana's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HempAmericana's stock is overvalued or undervalued compared to its peers.
Examining HempAmericana's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating HempAmericana's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HempAmericana's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of HempAmericana's pink sheet. These opinions can provide insight into HempAmericana's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating HempAmericana's pink sheet performance is not an exact science, and many factors can impact HempAmericana's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for HempAmericana Pink Sheet Analysis
When running HempAmericana's price analysis, check to measure HempAmericana's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HempAmericana is operating at the current time. Most of HempAmericana's value examination focuses on studying past and present price action to predict the probability of HempAmericana's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HempAmericana's price. Additionally, you may evaluate how the addition of HempAmericana to your portfolios can decrease your overall portfolio volatility.